Saturday, August 09, 2014 8:15:43 PM
1. good growth continues, however, They are still a ways off from turning a profit.
2.they are the only option for about 10% of epilepsy patients that don't respond to medication. Laser ablation for this set of patients is one of their core markets.
3. European Cleartrace set to lauch in Q4
4. The company is happy that Viualase (a company that they work hand in hand with to reduce the need for a surgery room and a MRI room to one room, reducing surgeon time and hospital use)was bought by Medtronic. They see the purchase price to be an indicator of the value of MRIC's potential value. They think Medtronic intends to grow the Visulase product. They are also happy with the expanded sales force that Medtronic brings. They will will get free sales from their efforts.They also think that the Medtronic buy is indicative of the validation of this form and direction of medicine.
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM